Vestal Point Capital, LP Macrogenics Inc Transaction History
Vestal Point Capital, LP
- $1.69 Trillion
- Q4 2024
A detailed history of Vestal Point Capital, LP transactions in Macrogenics Inc stock. As of the latest transaction made, Vestal Point Capital, LP holds 280,000 shares of MGNX stock, worth $666,400. This represents 0.05% of its overall portfolio holdings.
Number of Shares
280,000
Previous 830,000
66.27%
Holding current value
$666,400
Previous $2.73 Billion
66.68%
% of portfolio
0.05%
Previous 0.21%
Shares
4 transactions
Others Institutions Holding MGNX
# of Institutions
131Shares Held
56MCall Options Held
28.3KPut Options Held
197K-
Bellevue Group Ag Kuesnacht, V89.93MShares$23.6 Million0.64% of portfolio
-
Armistice Capital, LLC New York, NY6.28MShares$14.9 Million0.29% of portfolio
-
Black Rock Inc. New York, NY5.4MShares$12.9 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.32MShares$10.3 Million0.0% of portfolio
-
Wasatch Advisors Inc Salt Lake City, UT3.49MShares$8.3 Million0.06% of portfolio
About MACROGENICS INC
- Ticker MGNX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 61,458,800
- Market Cap $146M
- Description
- MacroGenics, Inc., a biopharmaceutical company, develops and commercializes antibody-based therapeutics to treat cancer in the United States. Its approved product is MARGENZA (margetuximab-cmkb), a human epidermal growth factor receptor 2 (HER2) receptor antagonist indicated, in combination with chemotherapy, for the treatment of adult patients ...